Lobbying

Envision Healthcare's latest lobbying report covers Q3 2026, at $10K. The four quarters Q4 2025–Q3 2026 total $831.2K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.

Envision Healthcare

Latest quarter
$10K
Q3 2026 · 1 reports
Last 12 months
$831.2K
Last 4 quarters
vs last quarter
−96.4%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Envision Healthcare lobbying by quarter
Envision Healthcare lobbying by quarter
QuarterAmountReports
Q4 2022$132.6K2
Q1 2023$132.6K2
Q2 2023$132.6K2
Q3 2023$132.6K2
Q4 2023$132.6K2
Q1 2024$132.6K2
Q2 2024$192K2
Q3 2024$225K2
Q4 2024$245K2
Q1 2025$245K2
Q2 2025$245K2
Q3 2025$264K2
Q4 2025$283K2
Q1 2026$257.1K2
Q2 2026$281.1K2
Q3 2026$10K1

Policy issues the reports name

  • Health issues31 reports
  • Medicare and Medicaid31 reports
  • Budget and appropriations3 reports
  • Immigration2 reports

A report that names several issues counts once for each.

Who was lobbied

  • Centers For Medicare and Medicaid Services (CMS)31 reports
  • Health & Human Services, Dept of (HHS)20 reports
  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports
  • Labor, Dept of (DOL)5 reports
  • Health Resources & Services Administration (HRSA)2 reports
  • Homeland Security, Dept of (DHS)2 reports

Firms it paid

Firm
In-houseEnvision Healthcare$2.6M15 quarters
McDermott+$460K16 quarters

Former officials lobbying for it

Former position
JEFFREY DAVIS2007-2008: Staff Assistant, Sen. Dianne Feinstein.Q3 2026
PATRICK VELLIKYLegislative Director, Congressman James B. Renacci (Feb 2014 - Sept 2015) Legislative Assistant, Congressman James B. Renacci (Jan 2011 - Oct 2011) Deputy Legislative Director, Senator Arlen Specter (April 2009 - Jan 2011)Q3 2025

Lobbying reports

Filed by
08/27for Q3McDermott+$10K
07/29for Q2In-house$251.1K
07/16for Q2McDermott+$30K
04/20for Q1In-house$227.1K
04/16for Q1McDermott+$30K
01/27for Q4 2025In-house$253K
01/12for Q4 2025McDermott+$30K
25/10/21for Q3 2025In-house$234K
25/10/03for Q3 2025McDermott+$30K
25/07/14for Q2 2025In-house$215K
25/06/27for Q2 2025McDermott+$30K
25/04/21for Q1 2025In-house$215K
25/03/31for Q1 2025McDermott+$30K
25/01/21for Q4 2024In-house$215K
25/01/06for Q4 2024McDermott+$30K
24/10/18for Q3 2024In-house$195K
24/10/03for Q3 2024McDermott+$30K
24/07/19for Q2 2024In-house$162K
24/07/08for Q2 2024McDermott+$30K
24/04/18for Q1 2024In-house$102.6K